The largest database of trusted experimental protocols

6 protocols using exendin 9 39 ex9

1

Adipogenesis Regulation through Wnt4 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture reagents, 5-bromo-2'-deoxyuridine (BrdU), anti-BrdU antibody, DNase I and TRIzol, were purchased from Life Technologies (Carlsbad, CA, USA). GLP-1, Exendin9-39 (Ex9), isobutylmethylxanthine (IBMX), dexamethasone (Dex), 4',6-diamidino-2-phenylindole (DAPI), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Oil Red O were acquired from Sigma Chemical (St. Louis, MO, USA). Complete Protease Inhibitor Cocktail was purchased from Roche Applied Science (Mannheim, Germany). TaKaRa PrimeScriptTM RT reagents kits and TaKaRa SYBR premix Ex Taq were acquired from TaKaRa Bio (Kyoto, Japan). Antibodies for β-catenin, (Ser37/Thr41) non-phospho-β-catenin and FITC-conjugated anti-rabbit and anti-mouse IgG antibodies were purchased from Cell Signaling Transduction (Boston, MA, USA). Antibodies for Wnt4 and GAPDH were acquired from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Lifectamine2000 and siRNA control were purchased from Life Technologies (Grand Island, New York, USA). All other chemicals of analytical grade were acquired from Dingguo Bio (Shanghai, China).
+ Open protocol
+ Expand
2

Liraglutide and Exendin 9-39 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liraglutide was obtained from Novo Nordisk (Bagsvaerd, Denmark). Exendin 9-39 (Ex9), naloxone, and other chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
3

Myricetin and Exendin 9-39 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myricetin (95%) was obtained from Acros Organics (Thermo Fisher, Geel, Belgium). Exendin 9–39 (Ex9), loperamide and naloxone and other chemicals or reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
4

Metabolic Profiling in Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Body weight and random fed blood glucose were monitored monthly for a total of 3 months. Fed (9:00 a.m.) and fasting (12-h fast, 9:00 p.m.) glucose, insulin, and glucagon levels were evaluated in 2-month-old males. Blood was obtained from the tail vein, and blood glucose was measured with Accu-Chek blood glucose meter. IP glucose tolerance tests (2 g/kg) and insulin tolerance tests (ITT) (0.75 units/kg) were performed by IP injections of respective agents in male mice fasted for 6 h. Hepatic glucose production was measured by IP injection of pyruvate (2 g/kg) (Sigma-Aldrich) and glycerol (2 g/kg) (Amresco) in mice fasted for 16 h (for pyruvate) and male mice fasted for 4 h (for glycerol). glucagon challenge was performed by IP injection of glucagon (100 μg/kg) (Sigma-Aldrich) in male mice fasted for 6 h. IP exendin 9-39 (Ex9) (50 μg/kg, cat. no. 4017799; Bachem) or vehicle (saline) was administered in fasted (4 h) control and αTSC2KO mice 15 min prior to IP glucose challenge (2 g/kg). Food intake and activity levels were recorded for the duration of 3 days with use of Comprehensive Lab Animal Monitoring System metabolic chambers (Columbus Instruments). Lean body mass and fat mass were determined by DEXA (Lunar Pixi, Janesville, WI).
+ Open protocol
+ Expand
5

Exendin-4 Modulation of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were pretreated with or without 10 nM or 100 nM Ex4 (Sigma–Aldrich) for 20 h, transfected with PIC transfection, and treated with or without Ex4 (10nM/100nM) again for 19 h before evaluation. In the experiments with inhibitors, cells were preincubated with 100 nM Exendin-(9–39) (Ex9, Sigma–Aldrich), 25 μM LY294002 (Cell Signaling, Danvers, MA, USA), or 5 μM H89 (Cell Signaling) for 30 min before treatment with 100 nM Ex4. The duration and concentration of Ex4 and inhibitor treatment were determined according to previous studies and used after ensuring that there was no cell toxicity.
+ Open protocol
+ Expand
6

Characterization of Proanthocyanidin-Enriched GSPE

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proanthocyanidin-enriched GSPE was obtained from Les Dérivés Résiniques et Terpéniques (Dax, France; Batch number: 124029). According to the manufacturer, the extract contains monomeric (21.3%), dimeric (17.4%), trimeric (16.3%), tetrameric (13.3%) and oligomeric (5–13 units; 31.7%) proanthocyanidins. GSPE were characterized in more detail by reverse-phase chromatographic analyses by our research group [23 (link)]. Briefly, the main compounds (up to tetramers) found in the GSPE lot used in this study were Gallic acid (31 mg/g), (epi)catechin (214 mg/g), epicatechin gallate (21 mg/g), procyanidin dimers (168 mg/g), procyanidin dimer gallate (9 mg/g) and trimers (5 mg/g). The phenolic content of the extracts was quantified using the Folin method [24 (link)] as 845.5 ± 10.5 mg/g GSPE. Gallic acid, exendin 9-39 (Ex9) and 70 kDa fluorescein isothiocyanate (FITC)-dextran were obtained from Sigma (St. Louis, MO, USA). GLP-1 7-36 amide was obtained from PolyPeptide (Limhamn, Sweden).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!